Clinical Trial Update: Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators [NA]

View source ↗

Summary

Clinical trial update on implantable cardioverter-defibrillators using enhanced SVT discriminators to reduce inappropriate shocks in patients with tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachycardia

Drugs mentioned

• Implantable cardioverter-defibrillator with enhanced SVT discriminators

Snippet

Sponsor: Abbott Medical Devices | Conditions: Tachycardia | NA | Status: COMPLETED